Miltefos 50 50 mg
0/5 (0) RatingsGeneric: Miltefosine
Category: Capsule
Manufacturer: Popular Pharmaceuticals Ltd.
Unclassified — prescription required · Upload a prescription at checkout. Pharmacist approval is required before preparation.
Currently unavailable to order.
Indications
Uses of Miltefos 50:
- Kala-azar
Visceral leishmaniasis, Mycosis fungoides, Skin metastases of breast cancer
Pregnancy, lactation, concurrent radiation therapy.
Dosage and Administration
How to use
Miltefosine:
Take this medicine in the dose and duration as advised by your doctor. Do not chew, crush or break it.
Miltefosine is to be taken with food.
Adult Dose:
Adult : PO Visceral Leishmaniasis 100-150 mg/day for 28 days.
Child Dose:
Child: PO 2.5 mg/kg/day bid
>12 y: 30–44 kg: 100 mg/day bid
>45 kg: 150 mg/day tid
Interaction
Miltefosine did not inhibit human cytochrome P450 enzymes in vitro.
Miltefosine did not induce cytochrome 3A activity in rats.
Contraindications
Pregnancy, lactation, concurrent radiation therapy.
Side Effects
Common
- Headache
- Nausea
- Itching
- Sleepiness
- Decreased appetite
- Abdominal pain
- Diarrhea
- Vomiting
- Dizziness
- Increased creatinine level in blood
- Increased liver enzymes
>10%
Visceral leishmaniasis
Increased transaminases, <3 x ULN (94%),Decreased platelets <150,000 (62%),Vomiting (37.8%),Decreased appetite (23.1%),Diarrhea (20.4%)
1-10%
Visceral leishmaniasis
Increased serum creatinine, >1.5 x baseline (10%),Asthenia (6.3%),Increased transaminases, 3-5 x ULN (6%),Decreased platelets <50,000 (2.4%)
Precautions And Warnings
Precaution:
Metastases grown over breast implants. Increased serum creatinine, ALT, AST, bilirubin reported; monitor. Thrombocytopenia reported; monitor platelets
Stevens-Johnson syndrome reported; discontinue if an exfoliative or bullous rash occurs
Lactation: Unknown if distributed in human breast milk; avoid breastfeeding during therapy and for 5 months following therapy
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Drug Classes
Leishmaniacides
Mode of Action
Miltefosine is a phospholipid derivative thought to work by disrupting cell-membrane function.
Pregnancy Category
Pregnancy: Miltefosine should not be used during pregnancy. Obtain a urine or serum pregnancy test in females of reproductive potential prior to prescribing.Nursing Mothers: Discontinue drug or nursing depending on the importance of drug to the mother. Avoid breastfeeding for 5 months after Miltefosine therapy.Females and Males of Reproductive Potential: Advise females to use effective contraception during therapy and for 5 months after therapy. Advise patients of reproductive toxicities in animals, and that the potential for impaired fertility in humans has not been adequately evaluated
Rating & Reviews
0.00/5
0 Ratings
Ratings reflect purchase experience: item condition when rated, otherwise pharmacy service.
No reviews found.
Samm Care